期刊文献+

老年肺癌患者外周血CD44表达及其临床意义 被引量:2

Clinical Significance on Expression of Peripheral Blood CD44 in elderly pat ients with Lung Cancer
暂未订购
导出
摘要 目的 :探讨老年肺癌患者外周血淋巴细胞中粘附分子CD4 4表达及其临床意义。方法 :用流式细胞术定量检测 6 6例老年肺癌患者外周静脉血中CD4 4水平 ,与正常人及慢性支气管炎患者进行相互对照 ,并通过自身对照分析手术前后或化疗前后的变化 ,应用统计学分析比较。结果 :老年肺癌组外周血CD4 4含量为 5 83 5 2± 18 6 4 ,明显高于正常人组 (42 8 37±14 2 5 ,P <0 0 1)及慢性支气管炎组 (44 2 6 3± 15 32 ,P <0 0 1) ,且手术前或化疗前的肺癌患者外周血CD4 4的表达也明显高于手术后或化疗后 (P <0 0 1或P <0 0 5 )。CD4 4的表达水平与患者病理类型不呈相关性 (P >0 0 5 ) ,但与临床分期和组织学分级相关 (P <0 0 1或P <0 0 5 )。结论 :外周血淋巴细胞中CD4 4含量可作为老年肺癌患者诊断的参考指标 ,其表达水平的变化可为临床判断患者疗效。 Objective:To as s ess clinical significance of expression of peripheral blood CD44 in lymphocyte w ith lung cancer.Methods:Peripheral blood CD44 contents in 66 elderly patients with lung cancer were detected by the method of immune flow cytometry,28 normal donors and 35 patients with chronic bronchitis served as controls.Results:CD44 contents have di fferent expression in three groups.Perip heral blood CD44 in lymphocyte with lung cancer(583.52±18.64)were significantly higher than those in chronic bronchitis( 442.63±15.32, P <0.01)and normal control s(428.37±14.25, P <0.01);There are no di stinct difference between CD44 in chronic bronchitis and normal controls( P >0.05 ).CD44 in lymphocyte with pre operation or pre chemotherapy was significantly hi gher than those in after operation or ch emotherapy( P <0.01 or P <0.05).The exp ression of CD44 was not related to patho logical typing ( P >0.05),but closely as sociated with clinical staging and histo pathological grading ( P <0.01 or P <0. 05).Conclusion:Peripheral blood C D44 contents in lymphocyte with elderly lung cancer might be used as a marker of diagnosis;The change of its expression will provide a clinical proof to judge t he curative effect and prognosis.
出处 《临床肿瘤学杂志》 CAS 2003年第1期42-44,共3页 Chinese Clinical Oncology
关键词 抗原CD44 流式细胞术 肺肿瘤 外周血 Antigen CD44 p rotein Flow cytometry Lung neoplasms Peripheral blood
  • 相关文献

参考文献5

二级参考文献20

  • 1徐建明,汤仲明,宋三泰,江泽飞,李家益,杨奕静.人乳腺癌原代培养体外药敏试验的评价[J].中华肿瘤杂志,1995,17(2):100-103. 被引量:22
  • 2[1]Koretz K, Moller P, Lehnert T, et al. Effect of CD44-V6 on survival in colorectal carcinoma[J]. Lancet, 1995, 345:327
  • 3[2]Salmi M, Gron-Virta K, Sointu P, et al. Regulated expression of exon v6 containing isoforms of CD44 in man: down-regulation during malignant transformation of tumors of squamocellular origin[J]. J Cell Biol, 1993, 122:431
  • 4[3]Haynes BE. Two major CD44-V6 proteins expressed on a metastatic breast cancer are derived from different splice variant[J]. Cancer Cell, 1991,3:347
  • 5[4]Gunthert U, Rudy W, Hofmann M, et al. A new variant of glycoprotein CD44-V6 confers metastatic potential to rat carcinoma cells[J]. Cell, 1991, 65:13
  • 6[5]Ermak G, Jennings T, Kobinson L, et al. Restricted pattern of CD44 variant exon expression in human papillary thyriod carcinoma[J]. Cancer Res, 1996,56(5):1037
  • 7[6]Matsumura Y. Expression of CD44-V6 adhesion molecule in colon carcinomas and metastases[J]. Lancet, 1992,340:1053
  • 8[7]Hirayama R, Sawai S, Takagi Y, et al. Positive relationship between expression of antimetastatic factor and good prognosis in human breast cacner[J]. J Natl Cancer Inst, 1991,83:1249
  • 9李俊.乳腺癌的新辅助化疗[J].国外医学(外科学分册),1997,24(1):29-31. 被引量:16
  • 10Cannon-albright LA, Goldgar DE,Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome9p13-p22[J].Science,1992;258(5085):1148~1152

共引文献66

同被引文献45

  • 1Buccoliero AM,Caldarella A,Arganini L,Mennonna P,Ammanati F,Taddei A,Taddei GL.Oligodendroglioma: CD44 as a possible prognostic opportunity[J].中国神经肿瘤杂志,2003,1(3):143-143. 被引量:8
  • 2邵小华,郜玉峰,李旭,余鑫之,周青,汪渊.CD44v6在原发性肝癌中的表达及其意义[J].安徽医药,2005,9(3):187-188. 被引量:4
  • 3仲宁,郑世营,陈锁成.CD44v6在肺癌组织中的表达及意义[J].江苏医药,2005,31(3):164-166. 被引量:6
  • 4Yong-Jun Liu,Pei-Song Yan,Jun Li,Jing-Fen Jia.Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer[J].World Journal of Gastroenterology,2005,11(42):6601-6606. 被引量:63
  • 5Birch M, Mitchell S,Hart IR.Isolation and characterization of human melanoma cell levels of CD44[J]. Cancer Res, 1991,51:6660.
  • 6Yamaguchi A, Zhang M, Goi T, et al. Expression of variant CD44 containing variantexon 810 in gallbladder cancer[J]. Oncol Rep, 2000, 7(3): 541.
  • 7Masson D, Dcins MC, Lnslenberger P. Limitations of CD44v6 amplification for the detection of tumor cells in the blood of colorectal cancer patients[J]. Br J Cancer, 2000,82(7):1283.
  • 8Yamao T,Matsumura Y, Shimada Y,et al. Abnormal expression of CD44 variants in the exfoliated cells in the lecos of patiente with colorectal cancer[J]. Gastroenterology, 1998, 114(6): 1196.
  • 9Tarin D. Matenmura Y. Deranged activity of the CD44 gene and other locias biomarkers for progression to metastatic maligmancy[J]. J Cell Biochern Suppl ,1993, 17G: 173.
  • 10Pereira PA, Rubenyhiran U, Kancko M. et al. CD44s expression mitigates the phenotype of human colorectal cancer hepstic metastases[J]. Anticancer Research,2001,21(4): 2713.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部